CAYLA KUBILUS: Open Payments
NPI 1629535026 · SEVERNA PARK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 12 payments from 5 companies in 2025. Trend: 2023 $93 · 2024 $107 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $74 |
| PFIZER INC. | 4 | $71 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Esperion Therapeutics, Inc. | 3 | $56 |
| Abbott Laboratories | 1 | $25 |
Products named: SAPIEN 3 Ultra RESILIA, ELIQUIS, LEQVIO, NEXLETOL, FREESTYLE LIBRE 3.
Industry payments across MD — which companies pay providers there.
